{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:11:31Z","timestamp":1789031491315,"version":"build-2803163510"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"abstract":"\n BACKGROUND:<\/jats:title>\n Intravenous thrombolysis remains the standard treatment for distal and medium vessel occlusion (DMVO) strokes. However, unlike large vessel occlusions, whether tenecteplase achieves higher early successful recanalization rates than alteplase in DMVO strokes remains uncertain.<\/jats:p>\n <\/jats:sec>\n \n METHODS:<\/jats:title>\n This single-center observational cohort study included consecutive patients with magnetic resonance imaging (MRI)-confirmed DMVO stroke treated at Centre Hospitalier Sud-Francilien, France, according to an institutional thrombolysis protocol specifying alteplase (0.9 mg\/kg, 2016\u20132018) or tenecteplase (0.25 mg\/kg, 2018\u20132023), with follow-up MRI 1 to 2 hours after intravenous thrombolysis. Patients intended for endovascular thrombectomy or without diagnostic-quality follow-up MRI were excluded. Recanalization was blindly assessed using a modified Arterial Occlusion Lesion scale designed for MRI and DMVO. Early successful recanalization was defined as \u226550% recanalization on early follow-up MRI (grade \u22652b), and substantial early infarct growth, assessed using a semiautomatic segmentation technique, was defined as a \u22650.5 mL and \u226520% increase in lesion volume. Propensity-score weighting accounted for baseline imbalances, including age, sex, vascular risk factors, baseline National Institutes of Health Stroke Scale score, occlusion site, and time period (2020\u20132023 versus 2016\u20132019).<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n \n Of the 319 included patients, 159 were treated with tenecteplase and 160 with alteplase. Median baseline National Institutes of Health Stroke Scale was 3 (1\u20137) in the tenecteplase group versus 4 (1\u20137.5) in the alteplase group, while M2 occlusions accounted for 54.1% versus 43.8% of cases. Early successful recanalization, assessed at a median postintravenous thrombolysis time of 80 (70\u201394) minutes, occurred in 72 (45.3%) and 53 (33.1%) patients treated with tenecteplase and alteplase, respectively (propensity-score weighting\u2013odds ratio, 1.59 [95% CI, 1.15\u20132.20];\n P<\/jats:italic>\n =0.005). Substantial early infarct growth was observed in 42 (26.8%) and 64 (40.5%) patients, respectively (propensity-score weighting\u2013odds ratio, 0.49 [95% CI, 0.35\u20130.69];\n P<\/jats:italic>\n <0.0001).\n <\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS:<\/jats:title>\n Compared with alteplase, tenecteplase-treated patients with DMVO had higher early successful recanalization and a lower risk of substantial early infarct growth, supporting its preferential use in this setting.<\/jats:p>\n <\/jats:sec>\n \n REGISTRATION:<\/jats:title>\n \n URL:\n https:\/\/www.clinicaltrials.gov<\/jats:ext-link>\n ; Unique identifier: NCT05635786.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1161\/strokeaha.125.054734","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:03:12Z","timestamp":1789030992000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Early Recanalization After Tenecteplase or Alteplase in Distal and Medium Vessel Occlusion Strokes: An Observational Cohort Study"],"prefix":"10.1161","clinical-trial-number":[{"clinical-trial-number":"nct05635786","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3512-1385","authenticated-orcid":true,"given":"Nicolas","family":"Chausson","sequence":"first","affiliation":[{"name":"Stroke Unit, H\u00f4pital Sud-Francilien, Corbeil-Essonnes, France (N.C., Y.L.H., D.S.)."},{"name":"Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, France (N.C., J.B., W.B.H., D.S., G.T.)."},{"name":"Universit\u00e9 Paris-Saclay, France (N.C., Y.L.H., D.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0733-0104","authenticated-orcid":true,"given":"Joseph","family":"Benzakoun","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, France (N.C., J.B., W.B.H., D.S., G.T.)."},{"name":"Neuroradiology, GHU Paris Psychiatrie et Neurosciences; Universit\u00e9 Paris Cit\u00e9, France (J.B., W.B.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3102-4315","authenticated-orcid":true,"given":"Sofia","family":"Vargas-Ibarra","sequence":"additional","affiliation":[{"name":"IBISC, Universit\u00e9 Evry, Universit\u00e9 Paris-Saclay, France (S.V.-I.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4718-8165","authenticated-orcid":true,"given":"Yann","family":"L\u2019Hermitte","sequence":"additional","affiliation":[{"name":"Stroke Unit, H\u00f4pital Sud-Francilien, Corbeil-Essonnes, France (N.C., Y.L.H., D.S.)."},{"name":"Universit\u00e9 Paris-Saclay, France (N.C., Y.L.H., D.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4858-3623","authenticated-orcid":true,"given":"Wagih","family":"Ben Hassen","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, France (N.C., J.B., W.B.H., D.S., G.T.)."},{"name":"Neuroradiology, GHU Paris Psychiatrie et Neurosciences; Universit\u00e9 Paris Cit\u00e9, France (J.B., W.B.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0671-8809","authenticated-orcid":true,"given":"Didier","family":"Smadja","sequence":"additional","affiliation":[{"name":"Stroke Unit, H\u00f4pital Sud-Francilien, Corbeil-Essonnes, France (N.C., Y.L.H., D.S.)."},{"name":"Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, France (N.C., J.B., W.B.H., D.S., G.T.)."},{"name":"Universit\u00e9 Paris-Saclay, France (N.C., Y.L.H., D.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5059-4095","authenticated-orcid":true,"given":"Guillaume","family":"Turc","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, France (N.C., J.B., W.B.H., D.S., G.T.)."},{"name":"Neurology Department, GHU Paris Psychiatrie et Neurosciences; Universit\u00e9 Paris Cit\u00e9, France (G.T.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00163-X"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2411668"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2408954"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/17474930231205213"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01054-6"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02600-9"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00377-6"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/23969873221150022"},{"key":"e_1_3_3_10_2","volume-title":"Metalyse: summary of product characteristics","author":"Boehringer Ingelheim International GmbH","year":"2024","unstructured":"Boehringer Ingelheim International GmbH. Metalyse: summary of product characteristics. European Medicines Agency. 2024. Accessed August 28, 2025. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/metalyse"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209903"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716405"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"e_1_3_3_14_2","volume-title":"Stroke: early management (alert, prehospital phase, initial hospital phase, indications for thrombolysis). Guidelines Department","author":"Haute Autorit\u00e9 de Sant\u00e9 (HAS)","year":"2009","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (HAS). Stroke: early management (alert, prehospital phase, initial hospital phase, indications for thrombolysis). Guidelines Department; 2009."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/23969873241254936"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.123.042491"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1177\/23969873221113729"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.030227"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2023.03713"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A7361"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2021-017321"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1511"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.502104"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.009775"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012915"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/SVIN.125.002022"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000258112.14918.24"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/STROKEAHA.125.054734","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:03:13Z","timestamp":1789030993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/STROKEAHA.125.054734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":27,"alternative-id":["10.1161\/STROKEAHA.125.054734"],"URL":"https:\/\/doi.org\/10.1161\/strokeaha.125.054734","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"2025-11-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"STROKEAHA.125.054734"}}